葡萄球菌肠毒素A的细胞增殖诱导能力

目的：观察葡萄球菌肠毒素Ａ的细胞增殖诱导能力及其抗肿瘤作用。方法：ＭＴＴ微量酶反应比色法。结果：纯化ＳＥＡ在１０＾－１２￣１０＾－１５ｇ／ｍｌ浓度范围对体外培养的ＢＡＬＢ／Ｃ鼠脾细胞表现了细胞增殖诱导能力,并呈剂量依赖关系,其中１０＾－７￣１０＾０５ｇ／ｍｌＳＥＡ的作用强于最适量（２５μｇ／ｍｌ）ＰＨＡ。在Ｅ／Ｔ为５￣２０：１条件下,１０＾－５ｇ／ｍｌＳＥＡ活化４８小时的ＢＡＬＢ／Ｃ鼠脾细胞对Ｙａｃ－１细胞的杀伤活性高于ＮＫ细胞,但ＳＥＡ未能增强ＢＡＬＢ／Ｃ鼠脾细胞对Ｂ１６细胞的杀伤活性。结论：葡萄球菌肠毒素Ａ具有较强的细胞增殖诱导能力,据此超抗原特性可应用于肿瘤的生物治疗。     

丹参有效成份764—3对血小板聚集和花生四烯酸代射产物的影响

７６４－３是从中药丹参中提取的有效成份，对ＡＡ和ＡＤＰ诱导的家兔和人血小板聚集有明显抑制作用，在以ＡＡ为底物，猪肺微粒体供酶系统中，小剂量７６４－３（５－１００μｇ／ｍｌ）明显促进６－ｋｅｔｏ－ＰＧＦ１ａ的生成，剂量与效应相关，大剂量７６４－３（５００μｇ／ｍｌ）对ＴＸＢ２和６ｋｅｔｏ－ＰＧＦ１ａ的生都有抑制作用，结果提示：小剂量７６４－３可能有利于ＴＸＢ２和６ｋｅｔｏ－ＰＧＦ１ａ平衡的调节。     

丹参有效成份764－3对血小板聚集和花生四烯酸代谢产物的影响

７６４－３是从中药丹参中提取的有效成份，对ＡＡ和ＡＤＰ诱导的家兔和人血小板聚集有明显抑制作用。在以ＡＡ为底物，猪肺微粒体供酶系统中，小剂量７６４－３（５－１００μｇ／ｍｌ）明显促进６－ｋｅｔｏ－ＰＧＦ１α的生成，剂量与效应相关。大剂量７６４－３（５００μｇ／ｍｌ）对ＴＸＢ２和６－ｋｅｔｏ－ＰＧＦ１α的生成都有抑制作用。结果提示：小剂量７６４－３可能有利于ＴＸＢ２和６－ｋｅｔｏ－ＰＧＦ１α平衡的调节。     

PDGF-AB对增生性瘢痕成纤维细胞增殖的影响

目的：探讨ＰＤＧＦ－ＡＢ促进伤口愈合的作用机理及其在瘢痕增生中的作用。方法：取体外培养的人正常皮肤及增生性瘢痕成纤维细胞（ＨＴＳＦＢ）测定生长曲线,用ＭＴＴ法观察ＰＤＧＦ－ＡＢ对其增殖影响的差异。结果：两种细胞生长曲线存在差异,ＰＤＧＦ－ＡＢ对两种成纤维细胞增殖均有明显刺激作用,且均呈剂量依赖性关系,但作用有差异。结论：ＰＤＧＦ－ＡＢ可能通过刺激成纤维细胞增殖促进伤口愈合,同时在瘢痕增生性疾病中起     

枸杞多糖对小鼠胸腺细胞凋亡的调节

目的：以ＤＥＸ诱导小鼠胸腺细胞凋亡为模型，研究中药枸杞多糖（ＬｙｃｉｕｍＢａｒｂａｒｕｍＰｏｌｙｄｓｃ－ｃｈａｒｉｄｅ．ＬＢＰ）及氧化苦参碱（ＯＸＹ）对胸腺细胞凋亡的调节作用。方法：应用ＰＩ法检测亚２倍体细胞，二苯胺法测定胸腺细胞ＤＮＡ片断化％及ＤＮＡ凝胶电泳。结果：ＬＢＰ可抑制ＤＥＸ诱导的ＤＮＡ片断化，其抑制作用具有剂量依赖性，以１ｇ／Ｌ最明显；ＬＢＰ（ｌｇ／Ｌ）尚可阻止ＤＥＸ诱导的胸腺细胞内Ｃａ￣（２＋）升高。结论：ＬＢＰ可抑制ＤＥＸ诱导的小鼠胸腺细胞凋亡，ＯＸＹ对此无明显的调节作用。     

IL－1α诱导牛脑微血管内皮细胞释放血小板衍生性生长因子

目的：研究白细胞介素－１α（ＩＬ－１α）诱导牛脑微血管内皮细胞（ＢＣＭＥＣ）释放血小板衍生性生长因子（ＰＤＧＦ），以及药物对由之引起的牛脑微血管平滑肌细胞（ＢＣＭＳＭＣ）增殖的拮抗作用。方法：体外培养ＢＣＭＥＣ和ＢＣＭＳＭＣ，结晶紫染色法测定细胞增殖。结果：ＩＬ－１α不能直接促进ＢＣＭＳＭＣ的增殖；但经ＩＬ－１α刺激的ＢＣＭＥＣ培养上清能显著地促进ＢＣＭＳＭＣ的增殖。这种增殖作用与ＩＬ－１α剂量呈正相关，并且可被抗ＰＤＧＦ抗体中和。欧芹素乙（Ｉｍｐ），异欧芹素乙（ｉｓｏ－Ｉｍｐ），６－（α，α－ｐｈｅｎｙ－ｌａｃｅｔｙｌｐｉｐｅｒａｚｉｎｙｌ）ｐｈｅｎｙｌ－５－ｍｅｔｈｙｌ－４，５－ｄｉｈｙｄｒｏ－３（２Ｈ）－ｐｙｒｉｄａｚｉｎｏｎｅ（ＰＭＤＰ）不影响ＩＬ－１α诱导ＢＣＭＥＣ释放ＰＤＧＦ，但对ＰＤＧＦ促ＢＣＭＳＭＣ增殖呈剂量依赖的拮抗。结论：ＩＬ－１α促进ＢＣＭＥＣ释放ＰＤＧＦ。ＩＬ－１α对ＢＣＭＳＭＣ增殖的促进作用需经ＰＤＧＦ等生长因子的介导。Ｉｍｐ，ｉｓｏ－Ｉｍｐ，ＰＭＤＰ拮抗ＰＤＧＦ引起的ＢＣＭＳＭＣ增殖。     

粉防己碱抑制大鼠肺动脉高压过程中PDGF-A、B表达的研究

目的：探讨血小板源生长因子（ＰＤＧＦ）在粉防己碱（Ｔｅｔ）抑制野百合碱（ＭＣＴ）诱导的大鼠肺动脉高压肺血管构形重建中的作用。方法：建立（ＭＣＴ）诱导的大鼠肺动脉高压模型,同进以两个实验组加不同剂量的Ｔｅｔ抑制肺动脉高压,用免疫组化方法检测Ｔｅｔ对ＭＣＴ致肺动脉高压在 肺小动脉中膜平滑肌细胞ＰＤＧＦ－Ａ、Ｂ表达的影响。结果：Ｔｅｔ能抑制肺小动脉中膜平滑肌细胞增殖时的ＰＤＧＦ－Ｂ的表达增强（Ｐ〈０．０     

黄颜木素对HSC—T6细胞增殖和胶原合成的影响

目的：研究黄颜木素对激活的永生型大鼠肝腑 脂细胞－－ＨＳＣ－Ｔ６细胞增殖和胶原合成的影响。方法：细胞增殖采用结晶紫染色法检测,胶原合成采用＾３Ｈ－酸掺入法分析。结果：黄颜木素（６．２５－５０．００μｍｏｌ／Ｌ）以剂量依赖方式显著抑制血小板源生长因子（ＰＤＧＦ）刺激的ＨＳＣ－Ｔ６细胞增殖,并抑制生长因子因子β１（ＴＧＦβ１）诱导的细胞内胶原合成,结论：黄颜木还给具有抑制激活的肝储脂细胞增殖和胶原合成     

绞股蓝总皂甙及与化疗药合用对体外培养慢粒急性变病人癌细胞增殖的影响

目的：观察绞股蓝总皂甙（ＧＰ）及ＧＰ与化疗药合用对体外培养慢性粒细胞性白血病急性变病人癌细胞增殖的影响。方法：用ＭＴＴ比色分析法测定ＧＰ及ＧＰ与阿糖胞苷（Ａｒａ－Ｃ）、高三尖杉酯碱ＨＨＲＴ分别合用对慢粒急变细胞的相对抑制率。结果：ＧＰ（１２．５～５０．０μｇ·ｍｌ－１）对体外培养慢性粒细胞性白血病急性变病人癌细胞具有明显抑制作用（Ｐ＜０．０５～０．０１）。ＧＰ（３．１２５μｇ·ｍｌ－１）同Ａｒａ－Ｃ（５．０μｇ·ｍｌ－１）、ＨＨＲＴ（６．７５μｇ·ｍｌ－１）分别合用相对抑制率（７７．０％，８６％）较单用Ａｒａ－Ｃ（１５．０μｇ·ｍｌ－１）或ＨＨＲＴ（２０．０μｇ·ｍｌ－１）的相对抑制率（４７％、４１％）高（Ｐ＜０．０５）。结论：１．ＧＰ对慢性粒细胞性白血病急性变病人癌细胞生长增殖具有抑制作用，呈剂量相关性。２．ＧＰ能增强阿糖胞苷、高三尖杉酯碱抑制增殖作用。     

Ge－132体外对ConA诱导的小鼠脾细胞表达IL3mRNA的影响

用斑点杂交法分析了Ｇｅ－１３２体外对ＣｏｎＡ诱导的小鼠脾细胞表达ＩＬ３ｍＲＮＡ的影响。结果Ｇｅ－１３２使鼠脾细胞表达ＩＬ３ｍＲＮＡ在２０ｈ左右达高峰，有效剂量范围较大（１０－３μｇ／ｍｌ～１００μｇ／ｍｌ），尤以１０－１μｇ／ｍｌ和１μｇ／ｍｌ两个剂量效果为佳，提示Ｇｅ－１３２促进造血的作用与其提高Ｔ细胞表达ＩＬ３有关。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…